Fortress Biotech (NASDAQ: FBIO)
Fortress Biotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Fortress Biotech Company Info
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
News & Analysis
Why Fortress Biotech Stock Is Sinking Today
The FDA refused to approve IV tramadol for the second time.
Why Fortress Biotech Stock Is Sinking Today
Investors were not thrilled with the company's latest regulatory update.
Why Fortress Biotech Stock Jumped Today
One of the company's subsidiaries announced some good news today.
Why Fortress Biotech Stock Is Plunging Today
One of the company's subsidiaries received some bad news today.
Coronado Biosciences Names New CEO
Coronado Biosciences taps Lindsay Rosenwald to lead the company.
Why Coronado Biosciences Is Poised to Keep Plunging
Market-lagging returns could be written in this 2-Star.
Why Coronado Biosciences Is Poised to Plunge
Market-lagging returns could be written in this 2-Star.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.